Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty
Open Access
- 1 March 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 27 (3) , 536-542
- https://doi.org/10.1016/0735-1097(95)00500-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Regulation of vascular integrins [published erratum appears in Blood 1994 Apr 1;83(7):2013]Blood, 1993
- Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profileJournal of the American College of Cardiology, 1992
- Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up.Circulation, 1991
- Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.Circulation, 1990
- The platelet membrane glycoprotein IIb-IIIa complexBlood, 1988
- Platelet Deposition at Angioplasty Sites and Platelet Survival Time After PTA in lliac and Femoral Arteries: Investigations with Indium-111-Oxine Labelled Platelets in Patients with ASA (1.0 g/Day)-TherapyThrombosis and Haemostasis, 1987
- Platelet accumulation in experimental angioplasty: time course and relation to vascular injury.Circulation, 1987
- Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Molecular Mechanisms of Platelet AggregationAnnual Review of Medicine, 1986
- Intracoronary thrombus: Role in coronary occlusion complicating percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1985